The immune response following COVID-19 vaccination involves two processes: cellular response—which generates diverse T-cell lineages, interferons, and interleukins—and the generation of IgG antibodies that target viral antigens, including protein S, triggered by the first process [29]. This evidence concerns the gene PROS1 and COVID-19.